Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. vs ABBOTT INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MARKSANS PHARMA. ABBOTT INDIA MARKSANS PHARMA./
ABBOTT INDIA
 
P/E (TTM) x 21.5 50.0 42.9% View Chart
P/BV x 3.9 18.2 21.6% View Chart
Dividend Yield % 0.3 1.2 27.4%  

Financials

 MARKSANS PHARMA.   ABBOTT INDIA
EQUITY SHARE DATA
    MARKSANS PHARMA.
Mar-23
ABBOTT INDIA
Mar-23
MARKSANS PHARMA./
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs7422,482 0.3%   
Low Rs3916,156 0.2%   
Sales per share (Unadj.) Rs40.92,517.0 1.6%  
Earnings per share (Unadj.) Rs5.9446.8 1.3%  
Cash flow per share (Unadj.) Rs7.0479.7 1.5%  
Dividends per share (Unadj.) Rs0.50325.00 0.2%  
Avg Dividend yield %0.91.7 52.5%  
Book value per share (Unadj.) Rs38.51,480.5 2.6%  
Shares outstanding (eoy) m453.1621.25 2,132.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.47.7 18.0%   
Avg P/E ratio x9.743.2 22.3%  
P/CF ratio (eoy) x8.140.3 20.1%  
Price / Book Value ratio x1.513.0 11.3%  
Dividend payout %8.572.7 11.7%   
Avg Mkt Cap Rs m25,631410,513 6.2%   
No. of employees `000NANA-   
Total wages/salary Rs m2,3945,636 42.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m18,52153,487 34.6%  
Other income Rs m5931,543 38.4%   
Total revenues Rs m19,11555,030 34.7%   
Gross profit Rs m3,39312,055 28.1%  
Depreciation Rs m519700 74.1%   
Interest Rs m91160 57.1%   
Profit before tax Rs m3,37712,738 26.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7233,244 22.3%   
Profit after tax Rs m2,6539,494 27.9%  
Gross profit margin %18.322.5 81.3%  
Effective tax rate %21.425.5 84.1%   
Net profit margin %14.317.8 80.7%  
BALANCE SHEET DATA
Current assets Rs m16,99730,251 56.2%   
Current liabilities Rs m3,65412,060 30.3%   
Net working cap to sales %72.034.0 211.8%  
Current ratio x4.72.5 185.5%  
Inventory Days Days687 6.6%  
Debtors Days Days822 3,798.1%  
Net fixed assets Rs m5,24615,135 34.7%   
Share capital Rs m453213 213.3%   
"Free" reserves Rs m16,99831,248 54.4%   
Net worth Rs m17,45231,460 55.5%   
Long term debt Rs m00-   
Total assets Rs m22,24245,386 49.0%  
Interest coverage x38.080.7 47.1%   
Debt to equity ratio x00-  
Sales to assets ratio x0.81.2 70.7%   
Return on assets %12.321.3 58.0%  
Return on equity %15.230.2 50.4%  
Return on capital %19.941.0 48.5%  
Exports to sales %00.4 0.0%   
Imports to sales %7.310.8 67.5%   
Exports (fob) Rs mNA221 0.0%   
Imports (cif) Rs m1,3485,765 23.4%   
Fx inflow Rs m6,491310 2,095.4%   
Fx outflow Rs m1,3485,818 23.2%   
Net fx Rs m5,143-5,508 -93.4%   
CASH FLOW
From Operations Rs m2,3748,934 26.6%  
From Investments Rs m-2,592-1,477 175.5%  
From Financial Activity Rs m1,978-6,387 -31.0%  
Net Cashflow Rs m1,7601,070 164.6%  

Share Holding

Indian Promoters % 43.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 20.3 8.9 227.8%  
FIIs % 15.6 0.2 8,638.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 56.2 25.0 224.5%  
Shareholders   237,377 72,252 328.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MARKSANS PHARMA. With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on MARKSANS PHARMA. vs Abbott India

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

MARKSANS PHARMA. vs Abbott India Share Price Performance

Period MARKSANS PHARMA. Abbott India S&P BSE HEALTHCARE
1-Day 0.46% 0.74% 1.18%
1-Month -0.72% -5.97% -0.75%
1-Year 109.61% 24.80% 61.82%
3-Year CAGR 45.11% 21.40% 18.16%
5-Year CAGR 43.62% 29.91% 19.79%

* Compound Annual Growth Rate

Here are more details on the MARKSANS PHARMA. share price and the Abbott India share price.

Moving on to shareholding structures...

The promoters of MARKSANS PHARMA. hold a 43.9% stake in the company. In case of Abbott India the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of MARKSANS PHARMA. and the shareholding pattern of Abbott India.

Finally, a word on dividends...

In the most recent financial year, MARKSANS PHARMA. paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 8.5%.

Abbott India paid Rs 325.0, and its dividend payout ratio stood at 72.7%.

You may visit here to review the dividend history of MARKSANS PHARMA., and the dividend history of Abbott India.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.